ACM
AGN

Axel Capital Management’s Allergan Inc AGN Stock Holding History

Axel Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-250
Closed -$31K – 51
2014
Q1 		$31K Hold
250
– – 0.07% 34
2013
Q4 		$28K Hold
250
– – 0.13% 24
2013
Q3 		$23K Hold
250
– – 0.6% 18
2013
Q2 		$21K Buy
+250
New +$25.9K 2.62% 19

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Axel Capital Management's AGN Position: Q2 2014 in Review

Axel Capital Management sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 250 shares — an estimated $31K sold.

Axel Capital Management first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $31K in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Axel Capital Management reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • Axel Capital Management sold 250 Allergan Inc shares in Q2 2014, an estimated $31K.
  • Axel Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • Axel Capital Management's Allergan Inc position peaked at $31K in Q1 2014.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Axel Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.